CoChat
Sign Up
Cited by 109

The DOI matches its Crossref record.

Bee venom allergy in beekeepers and their family members

Müller, Ulrich R·2005·Current Opinion in Allergy & Clinical Immunology
DOI 10.1097/01.all.0000173783.42906.95
Open this paper in CoChat — free account

Abstract

Purpose of review To analyze prevalence of allergic sting reactions, including the clinical and diagnostic features as well as management options in a population heavily exposed to honeybee stings such as beekeepers and their family members. Recent findings The higher sting frequency is associated with an increased prevalence of allergic sting reactions. Major risk factors for allergic sting reactions in beekeepers are: fewer than 10 annual stings, an atopic constitution and symptoms of upper respiratory allergy during work in the beehive. Bee venom allergic beekeepers have higher levels of bee venom-specific IgG but lower skin sensitivity and bee venom-specific IgE than normally exposed bee venom allergic patients. Safety of bee venom immunotherapy is higher in beekeepers than in allergic controls, while efficacy of this treatment is similar in both groups. Summary Beekeepers and their family members are at an increased risk of severe sting anaphylaxis and therefore need especially careful instruction with regard to avoidance of re-exposure, emergency treatment and specific immunotherapy with bee venom.

Overview

Integrity signals

Registry

Crossref · 10.1097/01.all.0000173783.42906.95

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 41

  1. Settipane, 1970, Prevalence of bee sting allergy in 4,992 boy scouts, Acta Allergol, 25, 286, 10.1111/j.1398-9995.1970.tb01264.x · DOI
  2. Charpin, 1989, Prevalence of clinical and biological signs of allergy to Hymenoptera stings in general population, J Allergy Clin Immunol, 83, 229
  3. Golden, 1989, Epidemiology of insect venom sensitivity, JAMA, 262, 240, 10.1001/jama.1989.03430020082033 · DOI
  4. Strupler, 1997, Prevalence of Hymenoptera venom allergy in Switzerland: an epidemiological and serological study based on data from SAPALDIA [in German], Allergo Journal, 6, 7
  5. Light, 1975, Clinical and immunological studies of beekeepers, Clin Allergy, 5, 389, 10.1111/j.1365-2222.1975.tb01878.x · DOI
  6. Yunginger, 1975, Measurement of IgE antibody to honeybee components in beekeepers and their family members, J Allergy Clin Immunol, 55, 74
  7. Miyachi, 1979, Comparison of the atopic background between allergic and non-allergic beekeepers, Int Arch Allergy Appl Immun, 58, 160, 10.1159/000232188 · DOI
  8. Bousquet, 1984, Clinical and immunologic survey in beekeepers in relation to their sensitization, J Allergy Clin Immunol, 73, 332, 10.1016/0091-6749(84)90405-6 · DOI
  9. Böhny, 1986, Professional inhalatory allergies in beekeepers [in German], Allergologie, 9, 337
  10. Annila, 1995, Clinical symptoms and immunologic reactivity to bee and wasp stings in beekeepers, Allergy, 50, 568, 10.1111/j.1398-9995.1995.tb01201.x · DOI
  11. de la Torre-Morin, 1995, Epidemiology of allergic reactions in beekeepers: a lower prevalence in subjects with more than 5 years exposure, Allergologia et Immunopathologia, 23, 127
  12. Müller, 1977, Serological investigations in Hymenoptera sting allergy: IgE and haemagglutinating antibodies against bee venom in patients with bee sting allergy, bee keepers and non-allergic blood donors, Clin Allergy, 7, 147, 10.1111/j.1365-2222.1977.tb01435.x · DOI
  13. Bousquet, 1982, Clinical and immunological surveys in bee keepers, Clin Allergy, 12, 331, 10.1111/j.1365-2222.1982.tb02537.x · DOI
  14. Annila, 1997, Risk assessment in determining systemic reactivity to honeybee stings in beekeepers, Ann Allergy Asthma Immunol, 78, 473, 10.1016/S1081-1206(10)63234-6 · DOI
  15. Day, 1994, Risk assessment in determining systemic reactivity to honeybee stings in sting-threatened individuals, J Allergy Clin Immunol, 93, 691, 10.1016/0091-6749(94)90249-6 · DOI
  16. Eich-Wanger, 1998, Bee sting allergy in beekeepers, Clin Exp Allergy, 28, 1292, 10.1046/j.1365-2222.1998.00411.x · DOI
  17. Settipane, 1972, Frequency of Hymenoptera allergy in an atopic and normal population, J Allergy Clin Immunol, 50, 146, 10.1016/0091-6749(72)90045-0 · DOI
  18. Huber, 1983, Atopy and generalized allergic reactions to insect stings [in German], Schweiz med Wochenschrift, 113, 1863
  19. Müller, 1993, Epidemiology of insect sting allergy, Monogr Allergy, 31, 131
  20. Aalberse, 1983, Serologic aspects of IgG4 antibodies. I. Prolonged immunization results in an IgG4-restricted response, J Immunol, 130, 722, 10.4049/jimmunol.130.2.722 · DOI
  21. Müller, 1978, Hymenoptera sting hypersensitivity: IgE, IgG and haemagglutinating antibodies to bee venom constituents in relation to exposure and clinical reaction to bee stings, Clin Allergy, 8, 267, 10.1111/j.1365-2222.1978.tb03223.x · DOI
  22. Garcia-Robaina, 1997, The natural history of Apis-specific IgG and IgG4 in beekeepers, Clin Exp Allergy, 27, 418, 10.1111/j.1365-2222.1997.tb00727.x · DOI
  23. Costa Manso, 1998, Honeybee venom specific IgG subclass antibodies in Brazilian beekeepers and in patients allergic to bee stings, Invest Allergol Clin Immunol, 8, 46
  24. Lessof, 1978, Effects of passive antibody in bee venom anaphylaxis, John Hopkins Medical Journal, 142, 1
  25. Müller, 1986, Combined active and passive immunotherapy in honeybee-sting allergy, J Allergy Clin Immunol, 78, 115, 10.1016/0091-6749(86)90123-5 · DOI
  26. Bousquet, 1987, Combination of passive and active immunization in honeybee venom immunotherapy, J Allergy Clin Immunol, 79, 947, 10.1016/0091-6749(87)90245-4 · DOI
  27. Müller, 1989, Predictive value of venom-specific IgE, IgG and IgG subclass antibodies in patients on immunotherapy with honey bee venom, Allergy, 44, 412, 10.1111/j.1398-9995.1989.tb04172.x · DOI
  28. Ollert, 2003, Results of a multicenter study on the predictive value of immunoblots during venom immunotherapy [in German], Allergo J, 12, S71
  29. Golden, 1992, Clinical correlation of the venom-specific IgG antibody level during maintenance venom immunotherapy, J Allergy Clin Immunol, 90, 386, 10.1016/S0091-6749(05)80019-3 · DOI
  30. Khan, 1990, Detection of anti-idiotypic antibodies to anti-bee venom (anti-BV) in non-reactive beekeeper's (NRB) and in persons on bee venom immunotherapy, J Allergy Clin Immunol, 85, 214
  31. Boutin, 1994, Possible dual role of anti-idiotypic antibodies in combined passive and active immunotherapy in honeybee sting allergy, J Allergy Clin Immunol, 93, 1039, 10.1016/S0091-6749(94)70053-2 · DOI
  32. Yu, 1995, Anti-IgE autoantibodies and bee-sting allergy, Allergy, 50, 119, 10.1111/j.1398-9995.1995.tb05067.x · DOI
  33. Jutel, 1995, Bee venom immunotherapy results in decrease of IL-4 and IL-5 and increase of IFN-γ secretion in specific allergen-stimulated T cell cultures, J Immunol, 154, 4187, 10.4049/jimmunol.154.8.4187 · DOI
  34. McHugh, 1995, Bee venom immunotherapy induces a shift in cytokine responses from a Th-2 to a Th-1 dominant pattern: comparison of rush and conventional immunotherapy, Clin Exp Allergy, 25, 828, 10.1111/j.1365-2222.1995.tb00025.x · DOI
  35. Akdis, 1996, Epitope-specific T cell tolerance to phospholipase A2 in bee venom immunotherapy and recovery by IL-2 and IL-5 in vitro, J Clin Invest, 98, 1676, 10.1172/JCI118963 · DOI
  36. Akdis, 1999, IL-10-induced anergy in peripheral T cell and reactivation by microenvironmental cytokines: two key steps in specific immunotherapy, FASEB J, 13, 603, 10.1096/fasebj.13.6.603 · DOI
  37. Blaser, 2004, Interleukin-10, T regulatory cells and specific allergy treatment, Clin Exp Allergy, 34, 328, 10.1111/j.1365-2222.2004.01909.x · DOI
  38. Taylor, 2004, T regulatory cells in allergy and health: a question of allergen specificity and balance, Int Arch Allergy Immunol, 135, 73, 10.1159/000080523 · DOI
  39. Mueller, 1966, Diagnosis and treatment of insect sensitivity, J Asthma Res, 3, 331, 10.3109/02770906609106941 · DOI
  40. Müller, 1993, Position paper: immunotherapy with Hymenoptera venoms, Allergy, 48, 37, 10.1111/j.1398-9995.1993.tb04755.x · DOI
  41. Lieberman, 2003, Use of epinephrine in the treatment of anaphylaxis, Curr Opin Allergy Clin Immunol, 3, 313, 10.1097/00130832-200308000-00013 · DOI

Cited by

Sorted by citations

Metadata

Authors
Müller, U. R.
Venue
Current Opinion in Allergy & Clinical Immunology
Publisher
Ovid Technologies (Wolters Kluwer Health)
Published
2005-08
Volume
5
Issue
4
Pages
343-347
ISSN
1528-4050
DOI
10.1097/01.all.0000173783.42906.95
Cited by
109
References
0
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review